Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Spruss

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Oncogene|February 2, 1999
The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53M Nevels, T Spruss, H Wolf, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexesT Spruss, G Bernhardt, E Schickaneder, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluationM Kager, T Spruss, M R Schneider, et al.
Archiv Der Pharmazie|February 1, 1992
Stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, Part III: Evaluation of the mammary tumor inhibiting propertiesS Schertl, R Gust, R Müller, et al.
International Journal of Pharmaceutics|May 9, 2002
Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenograftsW Vogelhuber, T Spruss, G Bernhardt, et al.
Journal of Virology|March 10, 2001
"Hit-and-run" transformation by adenovirus oncogenesM Nevels, B Täuber, T Spruss, et al.
Analytical Biochemistry|June 1, 1990
Computerized determination of growth kinetic curves and doubling times from cells in microcultureH Reile, H Birnböck, G Bernhardt, et al.
Archiv Der Pharmazie|February 1, 1990
Mammary tumor inhibiting properties of the (S,S)-configurated [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexT Spruss, R Gust, R Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor functionM Nevels, S Rubenwolf, T Spruss, et al.
Journal of Virology|May 9, 2000
Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 proteinM Nevels, S Rubenwolf, T Spruss, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Oncogene|February 2, 1999
The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53M Nevels, T Spruss, H Wolf, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexesT Spruss, G Bernhardt, E Schickaneder, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluationM Kager, T Spruss, M R Schneider, et al.
Archiv Der Pharmazie|February 1, 1992
Stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, Part III: Evaluation of the mammary tumor inhibiting propertiesS Schertl, R Gust, R Müller, et al.
International Journal of Pharmaceutics|May 9, 2002
Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenograftsW Vogelhuber, T Spruss, G Bernhardt, et al.
Journal of Virology|March 10, 2001
"Hit-and-run" transformation by adenovirus oncogenesM Nevels, B Täuber, T Spruss, et al.
Analytical Biochemistry|June 1, 1990
Computerized determination of growth kinetic curves and doubling times from cells in microcultureH Reile, H Birnböck, G Bernhardt, et al.
Archiv Der Pharmazie|February 1, 1990
Mammary tumor inhibiting properties of the (S,S)-configurated [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexT Spruss, R Gust, R Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor functionM Nevels, S Rubenwolf, T Spruss, et al.
Journal of Virology|May 9, 2000
Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 proteinM Nevels, S Rubenwolf, T Spruss, et al.
Pageof 5